MY171206A - A method of increasing the effect of an activated-potentiated form of an antibody - Google Patents
A method of increasing the effect of an activated-potentiated form of an antibodyInfo
- Publication number
- MY171206A MY171206A MYPI2013000107A MYPI2013000107A MY171206A MY 171206 A MY171206 A MY 171206A MY PI2013000107 A MYPI2013000107 A MY PI2013000107A MY PI2013000107 A MYPI2013000107 A MY PI2013000107A MY 171206 A MY171206 A MY 171206A
- Authority
- MY
- Malaysia
- Prior art keywords
- antibody
- activated
- potentiated form
- increasing
- effect
- Prior art date
Links
Abstract
The preset invention provides a method of increasing the effect of an activated-potentiated form of an antibody to an endogenous biological molecule by combining said endogenous biological molecule with an activated-potentiated form of an antibody to endothelial NO-synthase. The present invention also provides a pharmaceutical composition comprising a) an activated- potentiated form of an antibody to an endogenous biological molecule, and b) an activated-potentiated form of an antibody to NO synthase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2013000107A MY171206A (en) | 2011-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2011/002350 WO2012007845A2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
MYPI2013000107A MY171206A (en) | 2011-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
MY171206A true MY171206A (en) | 2019-10-02 |
Family
ID=79178335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2013000107A MY171206A (en) | 2011-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY171206A (en) |
-
2011
- 2011-07-15 MY MYPI2013000107A patent/MY171206A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121862T1 (en) | ANTI-PHF-TAU ANTIBODIES AND USES THEREOF | |
MX356337B (en) | Antibodies against human csf-1r and uses thereof. | |
AU2016204248A1 (en) | Boron-Containing Molecules | |
EP4036240A3 (en) | Transduction buffer | |
MX342034B (en) | Monovalent antigen binding proteins. | |
MX336682B (en) | Antibodies against human csf-1r and uses thereof. | |
WO2014074648A3 (en) | Riboregulator compositions and methods of use | |
WO2013060867A3 (en) | Production of heterodimeric proteins | |
ECSP14013339A (en) | COMPOUNDS WITH NEMATICIATED ACTIVITY | |
TW201129381A (en) | Antibodies against human CSF-1R and uses thereof | |
UA116092C2 (en) | Methods and compositions for weed control | |
LT2013016A (en) | A method of increasing the effect of an activated-potentiated form of an antibody | |
EA201590173A1 (en) | IMMUNOCONGUTS CONTAINING ANTIBODIES TO CD22 | |
EA201590887A1 (en) | COMPOSITION | |
EA201391389A1 (en) | CRYSTALS OF ANTIBODIES AGAINST SKLEROSTIN AND COMPOSITIONS ON THEIR BASIS | |
IN2012MU03723A (en) | ||
MX2014002996A (en) | Bispecific anti-egfr/anti igf-1r antibodies. | |
CL2012003491A1 (en) | Compound derived from dihydropyrrole substituted; process to prepare these derivatives in stereoselective form. | |
MX2015011781A (en) | Cell culture media and methods of antibody production. | |
UY33994A (en) | ANTIBODY MOLECULE OF DABIGATRAN AND DERIVATIVES AS ANTICOAGULANT ANTIDOTES | |
EA201490767A1 (en) | CLUSTER GENES BIOSYNTHESIS OF GRILLYLIMICINE AND METHYLRISYLIMICITY | |
EA201491300A1 (en) | COMPOSITION FOR BODY APPLICATION WITH IMPROVED STABILITY | |
WO2014037519A3 (en) | Compositions and methods | |
MX352837B (en) | Method for labeling intracellular and extracellular targets of leukocytes. | |
EA201391643A1 (en) | COMPOSITIONS WITH DELAYED PARACETAMOL DELIVERY |